Century Therapeutics, Inc.

Historical 13F Holders

Symbol
IPSC
CUSIP
15673T100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 15673T100 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13G
9.9% 1/16/2026
Event 1/9/2026
TCG Crossover GP II, LLC 13G
9.9% 1/15/2026
Event 1/9/2026
Deep Track Capital, LP 13G
7.3% 1/15/2026
Event 1/8/2026
Commodore Capital LP 13G
7.1% 1/16/2026
Event 1/9/2026
RTW Investments, LP 13G
7.1% 5/15/2026
Event 3/31/2026
Venrock Healthcare Capital Partners III, L.P. 13G
7.1% 1/16/2026
Event 1/9/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Bain Capital Life Sciences Opportunities III, LP 13G/A 4.1% 11/14/2025
Event 9/30/2025
Casdin Capital, LLC 13G/A
3.7% 5/15/2025
Event 3/31/2025
Point72 Asset Management, L.P. 13G/A
3.3% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 1.06 k $1.82 k
2026 Q2 105 158 M $389 M
2026 Q1 74 139 M $312 M
2025 Q4 47 25.7 M $25.6 M
2025 Q3 58 20.3 M $10.1 M
2025 Q2 68 22.6 M $12.6 M
2025 Q1 72 29.6 M $14.1 M
2024 Q4 75 36.4 M $36.8 M
2024 Q3 71 39.7 M $67.9 M
2024 Q2 67 40.4 M $103 M
2024 Q1 73 23.6 M $98.5 M
2023 Q4 69 18.0 M $59.8 M
2023 Q3 58 18.1 M $36.1 M
2023 Q2 67 19.3 M $61.0 M
2023 Q1 67 20.0 M $69.5 M
2022 Q4 70 21.2 M $109 M
2022 Q3 57 21.1 M $209 M
2022 Q2 57 21.8 M $183 M
2022 Q1 53 22.2 M $279 M
2021 Q4 51 21.1 M $335 M
2021 Q3 50 19.8 M $496 M
2021 Q2 37 16.9 M $491 M